An Immunotherapy Option for Treating Kidney Cancer
The FDA has approved an immunotherapy known as immune checkpoint inhibition for the treatment of certain patients with kidney...
Progress Against Cancer
Home »
The FDA has approved an immunotherapy known as immune checkpoint inhibition for the treatment of certain patients with kidney...
The FDA approved the chemotherapeutic azacitidine for patients with juvenile myelomonocytic leukemia The U.S. Food and Drug Administration (FDA)...
The FDA has granted full approval to an antibody-drug conjugate for certain patients with breast cancer. The U.S. Food...
The FDA approved the cellular immunotherapy axicabtagene ciloleucel for second-line treatment of patients with large B-cell lymphoma. The U.S....
The FDA has approved a radioactive compound and companion diagnostic test for patients with advanced prostate cancer. The U.S....
The FDA approved pembrolizumab for certain patients with advanced endometrial cancer with DNA repair defects The U.S. Food and...
The FDA approved nivolumab and relatlimab-rmbw (Opdualag) for some patients with advanced melanoma The U.S. Food and Drug...
The FDA approved olaparib for patients with breast cancer who have inherited BRCA mutations and have received prior neoadjuvant...
The FDA approved nivolumab in combination with chemotherapy for use before surgery in certain patients with non-small cell lung...
The FDA recently approved the second cellular immunotherapy to treat certain adult patients with multiple myeloma. The U.S. Food...